Racial/ethnic disparities in patient care experiences among prostate cancer survivors: A SEER-CAHPS study.

Authors

null

Ambrish Pandit

University of Arkansas for Medical Sciences, Little Rock, AR

Ambrish Pandit, Chenghui Li

Organizations

University of Arkansas for Medical Sciences, Little Rock, AR

Research Funding

No funding received
None.

Background: To evaluate racial/ethnic disparities in patient care experiences (PCEs) among prostate cancer (PCa) survivors. Methods: This retrospective study used 2007-2015 National Cancer Institute Surveillance, Epidemiology and End Results registry data linked to Consumer Assessment of Healthcare Providers and Systems surveys. First survey ≥6 months post-PCa diagnosis was analyzed. We performed linear regression modelling to evaluate the association of race/ethnicity (non-Hispanic White (NHW), non-Hispanic Black (NHB), Hispanic, non-Hispanic Asian (NHA), and other races) with PCE composite measures (getting needed care, doctor communication, getting care quickly, getting needed prescription drugs, customer service), and rating measures (primary physician, specialist, health plan, and overall care) adjusting for demographic and clinical covariates. Results: Among 7453 PCa survivors, NHAs (vs. NHWs) reported disparities in more PCE measures than any other racial/ethnic minority; reported lower scores for customer (ß = -7.58; p = 0.003), getting needed prescription drugs (ß = -3.08; p = 0.020) and specialist rating (ß = -2.32; p = 0.021) besides lower scores for getting care quickly. NHBs scored better on doctor communication (ß = 1.96; p = 0.006) and primary physician rating (ß = 1.28; p = 0.047) than NHWs. No statistically significant differences were found between other races and NHWs. Conclusions: Racial/ethnic minority PCa survivors reported worse experiences than NHW survivors on several PCE measures. Further research is needed to understand reasons behind these disparities and their influence on healthcare utilization and health outcomes among PCa survivors.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2022 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Cost, Value, and Policy,Health Care Access, Equity, and Disparities,Patient Experience

Sub Track

Provider Impact on Quality From the Patient Perspective

Citation

J Clin Oncol 40, 2022 (suppl 28; abstr 291)

DOI

10.1200/JCO.2022.40.28_suppl.291

Abstract #

291

Poster Bd #

G30

Abstract Disclosures

Similar Abstracts

Abstract

2023 ASCO Quality Care Symposium

The role of primary care in opioid prescribing for head and neck cancer (HNC) survivors.

First Author: Talya Salz

Abstract

2023 ASCO Quality Care Symposium

Status of survivorship care among young adult survivors of leukemia or lymphoma.

First Author: Susan K. Parsons

Abstract

2023 ASCO Quality Care Symposium

Loss to primary care provider follow-up among survivors five to seven years post-diagnosis.

First Author: Alexandra G. Peluso